Suppr超能文献

关于具有已证实或推测感染病因的淋巴瘤季节性发病情况的观察

Observations on seasonal occurrence in lymphomas with proven or presumed infectious etiology.

作者信息

Anagnostopoulos Ioannis, Buck Viktoria, Gerhard-Hartmann Elena, Zamó Alberto, Rosenwald Andreas, Rosenfeldt Mathias, Jöhrens Korinna

机构信息

Institute of Pathology, University of Würzburg, Würzburg, Germany.

Comprehensive Cancer Center Mainfranken, Würzburg, Germany.

出版信息

Front Oncol. 2025 Jul 8;15:1586441. doi: 10.3389/fonc.2025.1586441. eCollection 2025.

Abstract

INTRODUCTION

There are relatively few studies on seasonal occurrence of lymphomas, most dealing with Hodgkin lymphoma (HL). Most studies were based on small datasets leading to partly conflicting patterns and results with only two using the large Surveillance, Epidemiology and End Results database. By doing this, the study on HL showed a peak incidence in March and the lowest in September, while the study on a broadly defined B-cell lymphoma group identified a peak in March and April. Among the hypotheses regarding seasonal occurrence of lymphomas, a potential infectious etiology has been proposed, at least for some patient subgroups.

METHODS

For the present study, we used the files from one of Germany's lymphoma reference centers and addressed not only seasonal occurrence but also whether lymphoma entities with proven or suspected infectious etiology were associated with a particular seasonal clustering. We also investigated whether the COVID-19 pandemic (period 2020-21) influenced any observed seasonal patterns. Our study population comprised 8,038 cases with primary diagnosis of classic HL (CHL) including 2,434 cases with Epstein-Barr virus (EBV) infection of the neoplastic cells, 1,402 cases of nodular lymphocyte predominant HL, 487 cases with cutaneous marginal zone lymphoma (MZL), 247 cases with pulmonary MZL, 451 cases with hairy cell leukemia (HCL) and 4,577 cases with diffuse large B cell lymphoma (DLBCL).

RESULTS AND DISCUSSION

Our data show that among HL only CHL exhibited seasonal fluctuation with a peak in the first quarter and a trough in the third quarter of the year. Similar seasonal patterns were observed in the nodular sclerosing CHL subtype and the younger patient age group (0-39 years). No seasonal fluctuation was identified in lymphomas with proven (EBV-positive CHL) or presumed infectious etiology (cutaneous and pulmonary MZL, HCL). COVID-19 pandemic did not significantly influence the seasonal occurrence patterns observed in CHL.

摘要

引言

关于淋巴瘤季节性发病情况的研究相对较少,大多数研究针对霍奇金淋巴瘤(HL)。大多数研究基于小数据集,导致模式和结果部分相互矛盾,仅有两项研究使用了大型监测、流行病学和最终结果数据库。通过该数据库,HL研究显示发病率在3月达到峰值,9月最低,而对广义定义的B细胞淋巴瘤组的研究则确定3月和4月为发病高峰。在关于淋巴瘤季节性发病的假说中,有人提出了潜在的感染病因,至少对某些患者亚组是如此。

方法

在本研究中,我们使用了德国一个淋巴瘤参考中心的档案,不仅探讨了季节性发病情况,还研究了已证实或疑似感染病因的淋巴瘤实体是否与特定的季节性聚集有关。我们还调查了2019-2021年期间的新冠疫情是否影响了观察到的任何季节性模式。我们的研究人群包括8038例初诊为经典HL(CHL)的病例,其中2434例肿瘤细胞感染了爱泼斯坦-巴尔病毒(EBV),1402例结节性淋巴细胞为主型HL,487例皮肤边缘区淋巴瘤(MZL),247例肺MZL,451例毛细胞白血病(HCL)和4577例弥漫性大B细胞淋巴瘤(DLBCL)。

结果与讨论

我们的数据显示,在HL中,只有CHL呈现季节性波动,在第一季度达到高峰,第三季度出现低谷。在结节硬化型CHL亚型和较年轻的患者年龄组(0-39岁)中也观察到了类似的季节性模式。在已证实感染病因(EBV阳性CHL)或推测感染病因(皮肤和肺MZL、HCL)的淋巴瘤中未发现季节性波动。新冠疫情并未显著影响CHL中观察到的季节性发病模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e763/12279839/607c2737b420/fonc-15-1586441-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验